Other reports have highlighted high false-negative rates of HER2 quantitative reverse transcription provided by GHrs [37], significant numbers of false-negative ER and PR [38], and questionable proliferative assessments by GHrs [39] in well-differentiated low-grade invasive carcinoma that show mitotically active cellular stroma.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}